ChartRow logo
ChartRow
Investing Charts
Sign in
PODD
Insulet CorporationStock · HealthcareS&P 500 0.0%
$163.30+$4.92 (+3.11%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

How Insulet makes money

Period

How does Insulet make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Insulet Corporation · FY2025 · year ended 2025-12-31
Revenue$2.7BGross profit$1.9B · 72%Cost of revenue$768M · 28%Operating income$474M · 17%Operating expenses$1.5B · 54%R&D$301M · 11%SG&A$1.2B · 43%Pre-tax income$340M · 13%Other expense$134M · 5%Net income$247M · 9%Income tax$92M · 3%U.S.Omnipod$1.9B · 71%International Omnipod$754M · 28%Drug Delivery$34M · 1%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.